Home > Insider Trading > Filing (0001633970-15-000007)

Filing Details

Accession Number:: 0001633970-15-000007
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-19 20:14:33
Reporting Period:: 2015-02-13

Filing Date:: 2015-02-19
Accepted Time:: 2015-02-19 20:14:33
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1596783	Catalent Inc.	CTLT	Pharmaceutical Preparations (2834)	208737688

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1612208	Sharon Johnson	C/O Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-02-13	31,080	$10.71	46,473	No	4	M	Direct
Common Stock	Disposition	2015-02-13	20,950	$27.83	25,523	No	4	F	Direct
Common Stock	Disposition	2015-02-13	10,130	$27.82	15,393	No	4	S	Direct
Common Stock	Acquisiton	2015-02-13	18,320	$10.71	33,713	No	4	M	Direct
Common Stock	Disposition	2015-02-13	12,350	$27.83	21,363	No	4	F	Direct
Common Stock	Disposition	2015-02-13	5,970	$27.83	15,393	No	4	S	Direct
Common Stock	Acquisiton	2015-02-17	74,990	$10.71	90,383	No	4	M	Direct
Common Stock	Disposition	2015-02-17	50,787	$27.40	39,596	No	4	F	Direct
Common Stock	Disposition	2015-02-17	24,203	$27.40	15,393	No	4	S	Direct
Common Stock	Acquisiton	2015-02-17	2,862	$18.71	18,255	No	4	M	Direct
Common Stock	Disposition	2015-02-17	2,382	$27.40	15,873	No	4	F	Direct
Common Stock	Disposition	2015-02-17	480	$27.40	15,393	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options to purchase common stock	Disposition	2015-02-13	31,080	$0.00	31,080	$10.71
Common Stock	Options to purchase common stock	Disposition	2015-02-13	18,320	$0.00	18,320	$10.71
Common Stock	Options to purchase common stock	Disposition	2015-02-17	74,990	$0.00	74,990	$10.71
Common Stock	Options to purchase common stock	Disposition	2015-02-17	2,862	$0.00	2,862	$18.71

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2010-10-23	2019-10-23	No	4	M	Direct
74,990	2010-10-23	2019-10-23	No	4	M	Direct
0	2010-10-23	2019-10-23	No	4	M	Direct
26,258	2014-06-25	2023-06-25	No	4	M	Direct

Footnotes

Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options.
These shares were sold in multiple transactions at prices ranging from $28.00 to $28.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These shares were sold in multiple transactions at prices ranging from $27.30 to $27.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On October 23, 2009, the reporting person was granted an option to purchase 31,080 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments based on satisfaction of certain performance criteria for each of the fiscal years ending 2010, 2011, 2012, 2013 and 2014. The performance criteria for 2010, 2011, 2012, 2013 and 2014 were met.
On October 23, 2009, the reporting person was granted an option to purchase 93,310 shares of common stock of the Issuer, which vest and become exercisable in five equal annual installments beginning on October 23, 2010.
On June 25, 2013, the reporting person was granted an option to purchase 29,120 shares of common stock of the Issuer which vest and become exercisable in five equal annual installments based on satisfaction of certain performance criteria for each of the fiscal years ending 2014, 2015, 2016, 2017 and 2018. The performance criteria for 2014 were met, resulting in vesting of the option as to 5,824 shares.